Non Small Cell Lung Cancer With Egfr Mutation Clinical Trials

ReadTheTrial indexes 1 studies for Non Small Cell Lung Cancer With Egfr Mutation. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Non Small Cell Lung Cancer With Egfr Mutation.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials for Non Small Cell Lung Cancer With Egfr Mutation

Effect of Glutamine Plus Lactobacillus Reuteri Added to an Astringent Diet in Preventing Diarrhea Caused by Tyrosine Kinase Inhibitors (TKIs) in Patients With Advanced Non-small Cell Lung Cancer

NCT05852990 · RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Non Small Cell Lung Cancer With Egfr Mutation?

There are 1 clinical trials listed for Non Small Cell Lung Cancer With Egfr Mutation. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Non Small Cell Lung Cancer With Egfr Mutation trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Non Small Cell Lung Cancer With Egfr Mutation trials in?

Current Non Small Cell Lung Cancer With Egfr Mutation trials are distributed across: Phase 3 (1).

Find More Trials